Feedback / Questions
lenvatinib gel suspension (AIV007) - AiViva BioPharma
https://www.targetedonc.com/view/leap-002-trial-results-support-use-of-lenvatinib-monotherapy-in-uhcc-despite-missing-co-primary-end-points
Sep 10, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next